Taking your company public through an IPO is a crucial step, presenting a unique opportunity to benefit both your business and its investors. Explore the Nasdaq IPO Academy, a program tailored to ...

Median returns three months post IPO 2024 performance (the green line in Chart 5) were much better than the last two years (purple and pink lines). Importantly, 2024 IPOs as a group have so far held ...

The Company expects to receive aggregate gross proceeds of US$8,820,000 from this offering, before deducting underwriting discounts and offering expenses payable by the Company. In addition, the ...

Webus International Limited (the “Company”) (NASDAQ: WETO), a leading provider of AI-driven mobility solutions specializing in premium, customizable chauffeur services worldwide, today announced the ...

And while neither Orbital Reef nor Bezos' Blue Origin are public stocks you can invest in ... has announced an initial public offering (IPO). Because the details remain confidential, we know ...

The total gross proceeds of $10,125,000 from the initial public offering may be considered low for a company looking to establish a significant presence on the Nasdaq Capital Market. The offering ...

Clearly, if you had been lucky enough to pick up some shares at the company’s IPO price, you would have ... perform relative to some other popular stocks? Also, find out which stocks you should ...

Investors in defense stocks seem a bit nervous at the prospect ... Well, simply put, because Anduril might IPO soon. Since its establishment in 2017 (by, among others, Oculus founder Palmer ...

We recently compiled a list of the 10 Hot New Stocks to Buy Now. In this article, we are going to take a look at where U.S.

(RTTNews) - Maze Therapeutics, Inc., (MAZE), a clinical-stage biopharmaceutical company focused on developing small molecule precision medicines, has priced its initial public offering or IPO of 8 ...

OrbiMed Advisors LLC, a director at Sionna Therapeutics , Inc. (NASDAQ:SION), has made significant stock purchases, according to a recent filing. On February 10, 2025, OrbiMed acquired 550,000 shares ...